Hansa Biopharma Makes Leadership Appointments

Hansa Biopharma AB, which recently restructured and named a new CEO, has announced three leadership appointments:

• Brian Gorman joins Hansa as Chief Legal Officer and Corporate Secretary, effective August 4th
• Sandra Frithiof has been appointed Chief Human Resources Officer (CHRO), effective August 4th
• Kerstin Falck Lagercrantz will join the company on September 1st as Vice President Corporate Affairs

“We are very pleased to welcome Brian, Sandra and Kerstin to Hansa. They bring invaluable experience in their respective areas of expertise, which will be critical as we step up our U.S. pre-commercial activities, subject to data from two Phase 3 readouts and our first BLA submission,” said CEO Renée Aguiar-Lucander.

Brian Gorman, Chief Legal Officer & Corporate Secretary

Gorman is a legal and business executive with more than 20 years of global experience in advising corporate boards and management teams.

He joins Hansa from Sinclair Pharma Ltd., a global medical aesthetics company, where he was Chief Legal Officer supporting the company’s global expansion efforts. Prior to Sinclair, Gorman was Group General Counsel at Calliditas Therapeutics, where he guided the company through its acquisition by Asahi Kasei Corporation of Japan. Previously, Gorman was Executive Vice President, Corporate Development and General Counsel at Opiant Pharmaceuticals, where he played a key role in its acquisition by Indivior PLC. Earlier in his career, Gorman held senior leadership roles at Endo Pharmaceuticals and AstraZeneca. Gorman began his career at international law firm Cleary Gottlieb Steen & Hamilton, and he is a graduate of Gettysburg College and the Villanova University School of Law.

Sandra Frithiof, CHRO

Frithiof brings over 25 years of experience in human resources in different industries to Hansa.

Most recently, she was HR Director at Ayvens Sweden AB, a global leader in the mobility sector. Prior to Ayvens, Frithiof was VP Human Resources at Calliditas Therapeutics, where she built the Global HR organization to support the company’s entry into the US market. Previously, Frithiof was Head of HR and COO at Ramberg Advokater, a Swedish law firm and earlier in her career, Frithiof held HR positions at Karolinska University Hospital, UTC, CGI and Manpower Group. Frithiof has a bachelor’s degree in human resource management from Örebro University, Sweden. She will replace Anne Säfström Lanner, CHRO, who will leave the organization.

Brian Gorman and Sandra Frithiof will report to CEO Renée Aguiar-Lucander and be members of the Executive Committee.

Kerstin Falck Lagercrantz, Vice President Corporate Affairs

Lagercrantz will join Hansa from Pfizer AB, where she has spent over 20 years in various positions in corporate affairs and commercial operations.

Between 2014-2022, Lagercrantz held the role of Corporate Affairs Director where she was responsible for external communications, patient affairs, corporate social responsibility and crisis and issues management. During this time, she successfully implemented agreements and influenced several health policies during the COVID-19 pandemic. In addition, Lagercrantz has held several positions with SwedenBIO, including member of the board, and multiple roles with LIF (Swedish Pharmaceutical Industry Association). She has a Degree of Bachelor of Science in Business Administration and Economics, from Uppsala University, Sweden.

Lagercrantz will report to Maria Törnsén, Chief Operating Officer and US President, and she replaces Stephanie Kenney, former VP Corporate Affairs, who has left Hansa.